Apogee Therapeutics, Inc.

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

• Identityunclaimed
  Published
• Evidencesource_reported
  Published
• Evaluationnot_evaluated
  Published
• MonitoringNot yet published for this record.
  Not published
• AuthorityNot yet published for this record.
  Not published
• Freshnesscurrent
  Published

9 directors published. 8 of 9 with a published determination are independent.

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

• Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
• OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
• FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
• CompensationNot reviewed. Pay design shows how incentives are governed.
• GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
• Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
• AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
• LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
• RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
• CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
• AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
• Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
• Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
• Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
• Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
• Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
• This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

• CB
  Craig B. Thompson, M.D.Chief Medical Officer
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:15
• JP
  Jane Pritchett HendersonChief Financial Officer
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:16
• MH
  Michael Henderson, M.D.Chief Executive Officer
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:17
• AG
  Andrew Gottesdiener, M.D.Director
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:6
• JF
  Jennifer FoxDirector
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:7
• LB
  Lisa Bollinger, M.D.Director
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:8
• MC
  Mark C. McKennaDirector
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:9
• MH
  Michael Henderson, M.D.Director
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:10
• NS
  Nimish ShahDirector
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:11
• PH
  Peter HarwinDirector
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:12
• TK
  Tomas KiselakDirector
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:13
• WB
  William (BJ) Jones, Jr.Director
  company:72e207ff-72da-40c0-aca0-8b01c08b6b8a:leadership_role:14

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis

Published company record built from public sources

Sources

6 evidence records cited. 0 with redistribution rights.

Never published

Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry

Record claimed

No

Open disputes

0

Identity ownership

unclaimed

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

1. E1
   Alpha canonical company public projection

   Alpha canonical company public projection. canonical identity. Retrieved Sep 14, 2026. Cited by 5 Claims.
   Open web
   Rights not recorded, link only
   Evidence not pinned
2. E2
   Apogee Therapeutics DEF 14A 2025-04-29

   sec proxy. Published Apr 29, 2025. Retrieved Apr 24, 2026. Cited by 9 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
3. E3
   APGE DEF 14A executive officers

   sec filing. Published Apr 24, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
4. E4
   APGE DEF 14A executive officers

   sec filing. Published Apr 24, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
5. E5
   APGE DEF 14A executive officers

   sec filing. Published Apr 24, 2026. Retrieved May 14, 2026. Cited by 1 Claim.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned
6. E6
   Audit

   board_seats. board seats. Cited by 10 Claims.
   Authoritative, regulatory filing
   Rights not recorded, link only
   Evidence not pinned

• Craig B. Thompson, M.D. executive of Apogee Therapeutics, Inc., effective 2026-04-24.
• Jane Pritchett Henderson executive of Apogee Therapeutics, Inc., effective 2026-04-24.
• Michael Henderson, M.D. executive of Apogee Therapeutics, Inc., effective 2026-04-24.
• Lisa Bollinger, M.D. seat on Apogee Therapeutics, Inc., effective 2024-01-01.
• Andrew Gottesdiener, M.D. seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Jennifer Fox seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Mark C. McKenna seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Michael Henderson, M.D. seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Nimish Shah seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Peter Harwin seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Tomas Kiselak seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• William (BJ) Jones, Jr. seat on Apogee Therapeutics, Inc., effective 2023-01-01.
• Peter Harwin member of Audit, effective 2023-01-01.
• Audit · Chair; Compensation committee of Apogee Therapeutics, Inc., effective 2023-01-01.
• Jennifer Fox member of Audit · Chair; Compensation, effective 2023-01-01.
• Compensation · Chair committee of Apogee Therapeutics, Inc., effective 2023-01-01.
• William (BJ) Jones, Jr. member of Compensation · Chair, effective 2023-01-01.
• Compensation; Nominating and Governance · Chair committee of Apogee Therapeutics, Inc., effective 2023-01-01.
• Mark C. McKenna member of Compensation; Nominating and Governance · Chair, effective 2023-01-01.
• Nimish Shah member of Nominating and Governance, effective 2023-01-01.